Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 1.94% |
| 2 | Technology | 1.9% |
| 3 | Communication Services | 1.42% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOS
2226
PUT
Canada Goose Holdings
GOOS
$793M
| $16.6M | ﹤0.01% |
379,100
-55,100
| -13% | -$2.25M |
|
2227
CALL
Nano X Imaging
NNOX
$68.8M
| $16.6M | ﹤0.01% |
517,200
-52,400
| -9% | -$1.59M |
|
2228
iShares MSCI Mexico ETF
EWW
$1.8B
| $16.6M | ﹤0.01% |
345,157
+112,215
| +48% | +$5.3M |
|
2229
ICICI Bank
IBN
$108B
| $16.5M | ﹤0.01% |
967,544
+146,239
| +18% | +$2.43M |
|
2230
CALL
Globalstar
GSAT
$10.6B
| $16.5M | ﹤0.01% |
619,633
-216,954
| -26% | -$4.26M |
|
2231
CALL
Progyny
PGNY
$2.02B
| $16.5M | ﹤0.01% |
280,400
+149,300
| +114% | +$8.39M |
|
2232
Jazz Pharmaceuticals
JAZZ
$16.2B
| $16.5M | ﹤0.01% |
93,052
+63,568
| +216% | +$11M |
|
2233
PUT
L3Harris
LHX
$49B
| $16.5M | ﹤0.01% |
76,200
-4,400
| -5% | -$946K |
|
2234
CALL
Vanguard Dividend Appreciation ETF
VIG
$114B
| $16.4M | ﹤0.01% |
106,200
-103,500
| -49% | -$15.9M |
|
2235
TechnipFMC
FTI
$29.7B
| $16.4M | ﹤0.01% |
1,811,406
+1,031,505
| +132% | +$8.71M |
|
2236
Atossa Therapeutics
ATOS
$26.4M
| $16.4M | ﹤0.01% |
172,812
+169,528
| +5,162% | +$8.98M |
|
2237
CALL
Synaptics
SYNA
$3.74B
| $16.4M | ﹤0.01% |
105,200
-14,600
| -12% | -$1.97M |
|
2238
Chegg
CHGG
$87.7M
| $16.3M | ﹤0.01% |
196,317
+5,792
| +3% | +$480K |
|
|
MNDT
2239
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $16.3M | ﹤0.01% |
806,400
-183,400
| -19% | -$3.76M |
|
2240
Itaú Unibanco
ITUB
$83.9B
| $16.3M | ﹤0.01% |
3,722,235
-1,576,719
| -30% | -$6.35M |
|
2241
PUT
Takeda Pharmaceutical
TAK
$58.2B
| $16.3M | ﹤0.01% |
966,600
-1,245,800
| -56% | -$21.2M |
|
2242
CALL
Range Resources
RRC
$9.71B
| $16.3M | ﹤0.01% |
970,300
+238,300
| +33% | +$2.99M |
|
2243
PUT
Check Point Software Technologies
CHKP
$13.2B
| $16.3M | ﹤0.01% |
140,000
-33,300
| -19% | -$3.93M |
|
|
BRSL
2244
CALL
Brightstar Lottery PLC
BRSL
$2.1B
| $16.3M | ﹤0.01% |
678,500
+289,000
| +74% | +$6.05M |
|
|
QELL
2245
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
| $16.3M | ﹤0.01% |
1,633,239
+195,448
| +14% | +$1.94M |
|
2246
CALL
Schrodinger
SDGR
$1.46B
| $16.2M | ﹤0.01% |
214,000
-69,300
| -24% | -$5.02M |
|
2247
PUT
Darling Ingredients
DAR
$9.86B
| $16.2M | ﹤0.01% |
239,500
+227,400
| +1,879% | +$16M |
|
2248
PUT
W.P. Carey
WPC
$16.2B
| $16.2M | ﹤0.01% |
221,047
+51,357
| +30% | +$3.76M |
|
2249
CALL
Vuzix
VUZI
$225M
| $16.1M | ﹤0.01% |
878,900
+214,900
| +32% | +$4.34M |
|
2250
PUT
Verisk Analytics
VRSK
$24.5B
| $16.1M | ﹤0.01% |
92,300
-9,900
| -10% | -$1.76M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.